CD133和醛脱氢酶可能是胆管癌干细胞的分子标志物。 - Suppr

Suppr

超能文献

CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.

作者信息

Wang Min, Xiao Juan, Jiang Jianxin, Qin Renyi

出版信息

Int J Cancer. 2011 Apr 15;128(8):1996-7. doi: 10.1002/ijc.25519.

DOI:10.1002/ijc.25519

PMID:20568110

Abstract

摘要

相似文献

CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.CD133和醛脱氢酶可能是胆管癌干细胞的分子标志物。

Int J Cancer. 2011 Apr 15;128(8):1996-7. doi: 10.1002/ijc.25519.

Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers.具有干细胞亚型成分的肝细胞癌-胆管癌混合型的临床病理意义——与假定的干细胞标志物的表达相关。

Am J Clin Pathol. 2013 Sep;140(3):329-40. doi: 10.1309/AJCP66AVBANVNTQJ.

Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.乙醛脱氢酶可区分CD133肝癌干细胞群体。

Mol Cancer Res. 2008 Jul;6(7):1146-53. doi: 10.1158/1541-7786.MCR-08-0035.

Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.免疫组织化学分析浸润性乳腺癌及相关导管原位癌中的肿瘤干细胞标志物：与肿瘤乏氧和微血管标志物的关系。

Hum Pathol. 2013 Mar;44(3):402-11. doi: 10.1016/j.humpath.2012.06.004. Epub 2012 Oct 1.

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.醛脱氢酶与 CD133 联合定义了血管生成性卵巢癌干细胞，预示着患者预后不良。

Cancer Res. 2011 Jun 1;71(11):3991-4001. doi: 10.1158/0008-5472.CAN-10-3175. Epub 2011 Apr 15.

Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.癌症干细胞标志物醛脱氢酶1（ALDH1）和CD133在不同肺癌亚型中的差异表达

Cancer Invest. 2015;33(7):294-302. doi: 10.3109/07357907.2015.1034869. Epub 2015 Jun 5.

[Progress of research on breast cancer stem cell markers].[乳腺癌干细胞标志物的研究进展]

Zhonghua Bing Li Xue Za Zhi. 2014 Apr;43(4):282-4.

ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.ALDH 活性相对于 CD133 表达在人胰腺腺癌中选择性地定义了一个增强的肿瘤起始细胞群体。

PLoS One. 2011;6(6):e20636. doi: 10.1371/journal.pone.0020636. Epub 2011 Jun 13.

Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma.CD133和ALDH1癌症干细胞标志物表达在浸润性导管乳腺癌中的临床病理意义

Asian Pac J Cancer Prev. 2015;16(17):7491-6. doi: 10.7314/apjcp.2015.16.17.7491.

Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.胃癌原发灶及淋巴结转移组织中肿瘤干细胞标志物 ALDH1、CD44 和 CD133 的表达。

Pathol Int. 2012 Feb;62(2):112-9. doi: 10.1111/j.1440-1827.2011.02760.x. Epub 2011 Nov 30.

引用本文的文献

IL-8-NF-κB-ALDH1A1 loop promotes the progression of intrahepatic cholangiocarcinoma.白细胞介素-8-核因子-κB-醛脱氢酶1A1环路促进肝内胆管癌进展。

Hepatol Commun. 2025 Feb 26;9(3). doi: 10.1097/HC9.0000000000000664. eCollection 2025 Mar 1.

MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities.微小 RNA 与肝细胞癌发病机制：对机制和治疗机会的深入了解。

Int J Mol Sci. 2024 Aug 29;25(17):9393. doi: 10.3390/ijms25179393.

Mechanisms underlying the changes in acetaldehyde dehydrogenase 1 in cholangiocarcinoma.胆管癌中乙醛脱氢酶1变化的潜在机制。

J Cancer. 2023 Sep 25;14(17):3203-3213. doi: 10.7150/jca.86967. eCollection 2023.

MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen.MDACT：一种使用多种重新利用药物组合进行辅助癌症治疗的新原则及示例方案。

Cancers (Basel). 2022 May 23;14(10):2563. doi: 10.3390/cancers14102563.

Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.胆管癌中的癌症干细胞作用及其治疗意义。

Int J Mol Sci. 2019 Aug 25;20(17):4154. doi: 10.3390/ijms20174154.

A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas.替西罗莫司与脂质体阿霉素用于复发和难治性骨肉瘤及软组织肉瘤患者的II期研究。

Clin Sarcoma Res. 2018 Nov 5;8:21. doi: 10.1186/s13569-018-0107-9. eCollection 2018.

Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.促进胆管癌化疗耐药的自分泌和旁分泌机制

Int J Mol Sci. 2017 Jan 13;18(1):149. doi: 10.3390/ijms18010149.

Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.肝癌细胞起源、分子亚型及其对患者预后的影响。

Gastroenterology. 2017 Mar;152(4):745-761. doi: 10.1053/j.gastro.2016.11.048. Epub 2016 Dec 30.

Osteosarcoma: mouse models, cell of origin and cancer stem cell.骨肉瘤：小鼠模型、起源细胞与癌症干细胞

Postdoc J. 2014 Feb;2(2):19-30. doi: 10.14304/surya.jpr.v2n2.3.

Increased Oxidative Stress as a Selective Anticancer Therapy.增加氧化应激作为一种选择性抗癌疗法。

Oxid Med Cell Longev. 2015;2015:294303. doi: 10.1155/2015/294303. Epub 2015 Jul 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验